全髋关节置换术后假体周围感染相关的长期死亡率:一项包含4651例感染翻修病例的登记研究
该登记研究基于澳大利亚骨科协会国家关节置换登记系统(AOANJRR)1999年9月至2022年12月的数据,分析因骨关节炎行初次全髋关节置换术(THA)及后续翻修的死亡率。结果显示,因假体周围感染(PJI)翻修的患者5年、10年、15年累积死亡率为14.5%、34.7%、57.5%,其标准化死亡率比(SMR)为1.31(95%CI 1.24-1.39),高于初次THA(0.81)和无菌性翻修(0.95),且超额风险持续超过15年,尤其在年轻患者中更明显。
要点
- 因PJI翻修患者5年累积死亡率为14.5%,10年为34.7%,15年为57.5%。
- PJI翻修患者SMR为1.31,高于初次THA的0.81和无菌性翻修的0.95。
- PJI翻修后SMR在65岁以下患者和女性患者中更高,且持续增加超过15年。
核心结论
- 因感染翻修的患者相比一般人群、初次THA或无菌性翻修患者死亡率升高,超额风险持续超过15年,尤其在年轻患者中。
研究设计与样本
- 基于澳大利亚骨科协会国家关节置换登记系统(AOANJRR)的登记研究,纳入1999年9月至2022年12月因骨关节炎行初次THA及后续翻修的病例。
- 共记录548,061例因骨关节炎行初次THA,4,651例因感染行第一次翻修,15,891例因感染和骨折以外原因行第一次翻修。
- 采用Kaplan-Meier法估计生存率,基于澳大利亚时期寿命表计算标准化死亡率比(SMR),并使用Cox比例风险模型(校正年龄和性别)识别死亡危险因素。
主要发现
- 因PJI翻修患者5年、10年、15年累积死亡率分别为14.5%、34.7%、57.5%。
- PJI翻修患者SMR为1.31(95%CI 1.24-1.39),高于初次THA的0.81(95%CI 0.81-0.82)和无菌性翻修的0.95(95%CI 0.92-0.99)。
- PJI翻修后SMR在65岁以下患者和女性患者中更高,且持续增加超过15年。
- 根据PJI处理采用大翻修或小翻修,死亡率无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While the morbidity associated with revision total hip arthroplasty (THA) or periprosthetic infection (PJI) has been well characterized, less is known about the risk of mortality. With this study, we aimed to determine the long-term mortality associated with revision THA for PJI and associated risk factors. METHODS: Data from the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) were used to study mortality associated with THA procedures for osteoarthritis and subsequent revisions from September 1999 through December 2022. Kaplan-Meier estimates of survivorship and standardized mortality ratios (SMRs) based on Australian period life tables were used to summarize the overall survival following the primary and first revision THA. Risk factors associated with mortality were identified using Cox proportional hazards models, adjusted for age and gender. RESULTS: There were 548,061 primary THA procedures for osteoarthritis; 4,651 first revision procedures for infection and 15,891 first revisions for reasons other than infection and fracture were recorded. At 5, 10, and 15 years, the cumulative mortality rate for revision for PJI was 14.5%, 34.7%, and 57.5%, respectively. Patients who underwent revision for PJI had higher mortality rates than expected compared with the general population, and the corresponding SMR (1.31; 95% confidence interval [CI]: 1.24 to 1.39) was greater than that for patients undergoing primary THA (0.81; 95% CI: 0.81 to 0.82) or aseptic revision (0.95; 95% CI: 0.92 to 0.99). A higher SMR following revision for PJI was observed in patients <65 years of age and in female patients, and continued to increase beyond 15 years. There were no differences in mortality rates according to whether a major or minor revision was performed to manage PJI. CONCLUSIONS: Patients revised for infection had increased mortality rates compared with the general population and those undergoing primary THA or aseptic revision. This excess risk persisted beyond 15 years, especially in younger patients. LEVEL OF EVIDENCE: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
引用
- Campbell DG, Davis JS, de Steiger RN, et al. Long-Term Mortality Associated with Periprosthetic Infection in Total Hip Arthroplasty: A Registry Study of 4,651 Revisions for Infection. J Bone Joint Surg Am. 2025. PMID: 40460198. doi:10.2106/JBJS.24.01629
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。